Evaluation of Comprehensive COVID-19 Testing Program Outcomes in a US Dental Clinical Care Academic Setting.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Original Publication: Chicago, IL : American Medical Association, [2018]-

COVID-19 Testing* ; COVID-19*/diagnosis; Female ; Humans ; Young Adult ; Adult ; Male ; Pandemics/prevention & control ; SARS-CoV-2 ; Bayes Theorem ; Retrospective Studies

Importance: Although many academic institutions have implemented infection control and prevention protocols, including regular asymptomatic self-testing, in response to the COVID-19 pandemic, the outcomes of mandatory surveillance testing programs at academic dental institutions that offer direct patient-facing clinical care has not yet been reported.
Objective: To report the findings of a comprehensive surveillance COVID-19 testing program at an academic dental institution by assessing SARS-CoV-2 positivity rates and the potential association of test positivity with individual-level characteristics such as age, sex, and role.
Design, Setting, and Participants: A retrospective cohort study was conducted using SARS-CoV-2 self-testing data from a mandatory surveillance program at the Harvard School of Dental Medicine. Test results obtained between August 24, 2020, and February 28, 2022, from students, faculty, and staff members were analyzed. Testing cadence varied from 1 to 3 times per week depending on risk status. The association of individual characteristics with test positivity was evaluated with univariate analyses and a bayesian multilevel logistic regression model.
Exposures: Age by decade, sex, and role or position category (staff members, faculty, and students stratified by their involvement in clinical care activities), testing cadence, and testing date.
Main Outcomes and Measures: Positive results from SARS-CoV-2 real-time reverse transcription-polymerase chain reaction self-tests were assessed.
Results: Of the 390 study participants, 210 (53.8%) were women. Participants were grouped by age as follows: 20 to 29 years (190 [48.7%]), 30 to 39 years (88 [22.6%]), 40 to 49 years (44 [11.3%]), 50 to 59 years (42 [10.8%]), and 60 years or older (26 [6.7%]). Test results demonstrated an overall 0.27% positivity rate (61 test-positive cases), with a peak weekly positivity rate of 5.12% in the first week of January 2022. The mean (SD) test positivity rate among those involved in clinical activities was 0.25% (0.04) compared with 0.36% (0.09) among nonclinical participants. When adjusting for all considered covariates, test positivity was significantly associated with testing frequency (3 times vs 1 time per week: odds ratio [OR], 1.51 [95% credible interval (CrI), 1.07-3.69]) and timing of the test (after vs during the Alpha wave: OR, 0.33 [95% CrI, 0.11-0.88]; and Omicron vs Alpha: OR, 11.59 [95% CrI, 6.49-22.21]) but not with individual characteristics (age, sex, and role).
Conclusions and Relevance: These findings suggest that implementing an adaptive testing cadence based on the risk status of individuals may be effective in reducing the risk of SARS-CoV-2 infection within an institution. In this study, involvement in clinical activities did not pose additional risk of SARS-CoV-2 infection compared with other in-person activities in the presence of these control measures.

J Dent Res. 2020 May;99(5):481-487. (PMID: 32162995)
Int J Environ Res Public Health. 2020 Jul 02;17(13):. (PMID: 32630735)
Emerg Infect Dis. 2021 Oct;27(10):2604-2618. (PMID: 34545792)
Clin Microbiol Infect. 2021 Jan;27(1):155-156. (PMID: 32822884)
Nat Rev Genet. 2021 Jul;22(7):415-426. (PMID: 33948037)
Epidemiology. 2022 Mar 1;33(2):209-216. (PMID: 34860727)
Nat Biotechnol. 2020 Apr;38(4):382-384. (PMID: 32265548)
JAMA Netw Open. 2021 Dec 1;4(12):e2137257. (PMID: 34905008)
JAMA Netw Open. 2020 Jul 1;3(7):e2016818. (PMID: 32735339)
Arch Environ Occup Health. 2022;77(6):455-467. (PMID: 34047677)
J Dent Educ. 2020 Jun;84(6):718-722. (PMID: 32342516)
Epidemics. 2021 Dec;37:100527. (PMID: 34814094)
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1743-1747. (PMID: 33211678)
Rocz Panstw Zakl Hig. 2021;72(1):95-101. (PMID: 33883104)
J Infect Public Health. 2020 Nov;13(11):1630-1638. (PMID: 32855090)
Eur J Dent Educ. 2020 Nov;24(4):825-827. (PMID: 32654328)

Date Created: 20221213 Date Completed: 20221215 Latest Revision: 20230204

20240628

PMC9856527

10.1001/jamanetworkopen.2022.46530

36512355